Breaking Down Assura Plc Financial Health: Key Insights for Investors

Assura Plc's latest results demand a close look: total revenue jumped 16.5% to £183.8 million year-on-year, driven by a 17% rise in net rental income to £167.1 million after acquiring 14 private hospitals and completing five developments, while the portfolio now spans 608 properties serving over six million patients and an annualized rent roll of £176.9 million; profitability showed strength with EPRA earnings of £111.8 million (EPRA EPS 3.5p) and an IFRS profit before tax of £166.0 million versus a £28.7 million loss in 2024, even as net debt climbed to £1.487 billion and LTV rose to 49% (net debt/EBITDA 9.8x targeted below 9x via disposals), liquidity is supported by a weighted average interest rate of 2.9% and 98% fixed/capped facilities, and valuation metrics place intrinsic value at £38.75 per share - about 18.4% below the current market price of £47.48 - so read on for a chapter-by-chapter breakdown of revenue drivers, profitability, debt structure, liquidity, valuation and the key risks and growth opportunities shaping investor decisions.

Assura Plc (AGR.L) Revenue Analysis

Assura Plc reported strong top-line growth for the year ending 31 March 2025, driven by M&A, development completions and robust like‑for‑like rental performance across its healthcare property portfolio.

• Total revenue: £183.8m in 2025 vs £157.8m in 2024 (+16.5%).
• Net rental income: £167.1m in 2025, up 17% year‑on‑year, supported by acquisitions and completed developments.
• Annualized rent roll: £176.9m, with like‑for‑like rental growth of 6.1% in 2024/25.
• Portfolio: 608 properties serving >6 million patients across the UK & Ireland.
• Disposals completed: £188m (small premium to book), including sales into the JV and a £24m portfolio sale to a third party.

Key operational moves supporting revenue growth:

• Acquisition of 14 independent hospitals (added recurring rent and service income).
• Completion of five development projects (new lettable income and pipeline upside).
• Selective disposals (£188m) executed at a small premium to book to recycle capital into higher yielding opportunities and JV structures.

For broader context on Assura's strategy, history and how it generates returns, see: Assura Plc: History, Ownership, Mission, How It Works & Makes Money

Assura Plc (AGR.L) - Profitability Metrics

Assura Plc reported a clear improvement in underlying profitability in the latest reporting period, driven by higher EPRA earnings and a return to IFRS profit before tax. Key headline figures are summarized below.

• EPRA earnings rose 9.3% to £111.8 million; EPRA EPS increased to 3.5p (from 3.4p in 2024).
• IFRS profit before tax: £166.0 million (versus a loss of £28.7 million in 2024).
• Net finance costs (through EPRA earnings): £41.4 million (2024: £27.2 million).
• Weighted average interest rate on debt: 2.9% (2024: 2.3%).
• Net debt to EBITDA: 9.8x, with a stated target to reduce below 9x via capital recycling.
• Dividend yield maintained at 7.22%, supported by an annualised rent roll of £177.9 million.

Primary drivers behind the numbers:

• Higher EPRA earnings reflect stable rental income and operational control.
• IFRS profit recovery benefited from revaluation gains and improved operating margins.
• Rising finance costs and higher average interest rate pressure headline profitability; management is targeting leverage reduction.
• Dividend yield remains attractive relative to peers, underpinned by a £177.9m annualised rent roll.

For background on the group and business model, see: Assura Plc: History, Ownership, Mission, How It Works & Makes Money

Assura Plc (AGR.L) - Debt vs. Equity Structure

Assura Plc (AGR.L) entered the period with a capital structure skewed towards higher leverage, reflecting continued asset-backed borrowing against a large primary care property portfolio. Key headline movements and targets for deleveraging and liquidity management are outlined below.

• Net debt: £1.487 billion (up from £1.217 billion in 2024).
• Loan-to-value (LTV): 49% (up from 45% in 2024); management target to reduce LTV below 45% via asset disposals.
• Net debt / EBITDA: 9.8x, with a stated target to reduce below 9.0x through capital recycling.
• Weighted average debt maturity: 4.6 years; longest-dated facilities mature in 2030 and 2033.
• Interest rate protection: 98% of debt facilities at fixed or capped rates.
• Disposals completed: £188 million (sold at a small premium to book value), including £24 million sold to a third party and remaining sales into the joint venture.

Implications for investors center on leverage reduction timelines, the speed and pricing of further disposals, and maintenance of interest-rate protection. For context on ownership trends and investor flows that may interact with capital markets access, see Exploring Assura Plc Investor Profile: Who's Buying and Why?

Assura Plc (AGR.L) - Liquidity and Solvency

• Weighted average interest rate on debt: 2.9% (up from 2.3% in 2024)
• Weighted average debt maturity: 4.6 years
• Longest-dated facilities maturing: 2030 and 2033
• Proportion of debt at fixed or capped rates: 98%

• Capital recycling: management completed £188m of disposals (including sales into the joint venture and a £24m portfolio sale to a third party) to generate proceeds and reduce leverage.
• Interest-rate protection: 98% of facilities fixed or capped, limiting earnings volatility from rate moves despite the weighted average rate rising to 2.9%.
• Maturity profile: the 4.6‑year average maturity and long-dated facilities to 2030 and 2033 reduce near-term refinancing pressure.
• Deleveraging plan: focus on further disposals and capital recycling to push net debt/EBITDA below the 9x target.

Assura Plc (AGR.L) Valuation Analysis

• Intrinsic value per share: £38.75
• Market price per share: £47.48
• Implied premium to intrinsic value: 18.4%

• Leverage: Net debt / EBITDA at 9.8x - management plan targets sub‑9.0x via ongoing disposals and JV transactions.
• Interest-rate exposure: Weighted average cost of debt 2.9% (vs 2.3% in 2024), but 98% of facilities are fixed or capped, limiting near-term re-pricing risk.
• Maturity profile: Average life 4.6 years with major maturities in 2030 and 2033 - manageable refinancing runway if capital recycling targets met.
• Disposals: £188m realized at a small premium to book - demonstrates market appetite for diagnostic/primary-care assets and helps fund deleveraging.

Assura Plc (AGR.L) - Risk Factors

• Execution risk on the disposal programme: failure to complete targeted capital recycling could delay reduction in leverage and put pressure on the company's credit rating.
• Market volatility and takeover activity: a £1.6 billion bid from KKR and Stonepeak was rejected in February and revised upward in March, demonstrating sensitivity of the share price and strategic uncertainty.
• High leverage relative to earnings: net debt to EBITDA stood at 9.8x, above management's target of reducing leverage to below 9x through disposals and recycling of capital.
• Rising effective financing cost: weighted average interest rate on debt increased to 2.9% (from 2.3% in 2024), raising interest expense risk if rates continue to climb.
• Maturity concentration: weighted average debt maturity is 4.6 years with the longest-dated facilities maturing in 2030 and 2033 - refinancing risk exists if capital markets deteriorate.

Key operational and financial sensitivities for investors include execution of asset disposals, refinancing environment over the 4-7 year horizon, and potential rating pressure should leverage remain above plan. For broader context on corporate strategy and how Assura operates, see Assura Plc: History, Ownership, Mission, How It Works & Makes Money

Assura Plc (AGR.L) - Growth Opportunities

• £250m joint venture with USS dedicated to net-zero carbon healthcare facilities - aligns with NHS net-zero mandate by 2045 and supports long-term contracted cash flows.
• Five net-zero developments completed in 2024/25; committed pipeline of £8.3m for 2025/26, demonstrating operational delivery capability in sustainable builds.
• Operating portfolio of over 600 healthcare buildings providing predictable, defensive income linked to public-sector occupancy.
• Active disposal discussions for a further £19m of assets held for sale to accelerate capital recycling and debt reduction.

• Capital recycling strategy: sales (including the £19m under discussion) to drive net debt / EBITDA toward sub‑9x.
• ESG-led growth: JV and net-zero completions position Assura to capture NHS and public-sector demand for modern, low-carbon facilities.
• Operational resilience: a diversified base of 600+ healthcare properties supports stable rent roll and predictable cash flow, reducing cyclical exposure.